Penumbra (PEN) Price & Analysis

Compare

442 Followers

PEN Stock Chart & Stats

Day’s Range― - ―

52-Week Range$148.00 - $310.00

Previous CloseN/A

Volume93.15K

Average Volume (3M)411.42K

Market Cap

$9.16B

Enterprise Value$9.00B

Total Cash (Recent Filing)$378.85M

Total Debt (Recent Filing)$220.66M

Price to Earnings (P/E)219.9

Beta0.63

Next Earnings

Jul 29, 2025

EPS Estimate

0.83

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.83

Shares Outstanding38,725,940

10 Day Avg. Volume342,862

30 Day Avg. Volume411,419

Financial Highlights & Ratios

PEG Ratio1.06

Price to Book (P/B)7.57

Price to Sales (P/S)0.00

P/FCF Ratio61.35

Enterprise Value/Market Cap0.98

Enterprise Value/Revenue1.90

Enterprise Value/Gross Profit11.43

Enterprise Value/Ebitda50.92

Forecast

1Y Price Target

$313.17

Price Target Upside33.60% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering16

Penumbra News

See All News >

Bulls Say, Bears Say

Bulls Say

Earnings GrowthPenumbra is expected to have one of the most attractive combined sales and earnings growth profiles across coverage over the next two-plus years.

Market PenetrationVascular thrombectomy is expected to be the biggest growth driver for Penumbra, with the market only roughly 10% penetrated, suggesting substantial growth potential.

Product LaunchThe Thunderbolt product is considered a potential 'game changer' that could provide a price lift and help improve market growth, adding an estimated 100-200 basis points to overall growth.

Bears Say

Manufacturing CostsManagement expects higher Thrombectomy product mix to be offset by higher manufacturing investments to support new product launches, which is expected to drive Q2/25 GM to be similar/lower than Q1/25.

Price Target ChallengesPEN's relative premium to profitable peers now sits at a fairly steep level, making it tough to lift the price target despite being a best-in-class innovator.

Revenue GuidanceDespite earlier growth of 17% in the first quarter, management is comfortable with a conservative revenue growth guidance of 12-14%, indicating confidence in stable performance.

Financials

Income Statement >

Options Prices

Detailed Option Prices >

Ownership Overview

2.95% Insiders

40.18% Mutual Funds

― Other Institutional Investors

34.86% Public Companies and Individual Investors

Detailed Ownership Overview >

PEN FAQ

What was Penumbra’s price range in the past 12 months?

Penumbra lowest stock price was $148.00 and its highest was $310.00 in the past 12 months.

What is Penumbra’s market cap?

Penumbra’s market cap is $9.16B.

When is Penumbra’s upcoming earnings report date?

Penumbra’s upcoming earnings report date is Jul 29, 2025 which is in 11 days.

How were Penumbra’s earnings last quarter?

Penumbra released its earnings results on Apr 23, 2025. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.667 by $0.163.

Is Penumbra overvalued?

According to Wall Street analysts Penumbra’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Penumbra pay dividends?

Penumbra does not currently pay dividends.

What is Penumbra’s EPS estimate?

Penumbra’s EPS estimate is 0.83.

How many shares outstanding does Penumbra have?

Penumbra has 38,725,940 shares outstanding.

What happened to Penumbra’s price movement after its last earnings report?

Penumbra reported an EPS of $0.83 in its last earnings report, beating expectations of $0.667. Following the earnings report the stock price went up 6.988%.

Which hedge fund is a major shareholder of Penumbra?

Currently, no hedge funds are holding shares in PEN

Penumbra Stock Smart Score

Outperform

Fundamentals

Return on Equity

3.50%

Trailing 12-Months

Asset Growth

0.85%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Penumbra

Penumbra, Inc. is a global healthcare company that designs, develops, manufactures, and markets innovative medical devices for the treatment of various medical conditions. The company operates primarily in the neuro and peripheral vascular sectors, providing minimally invasive solutions that address challenging medical conditions such as stroke and vascular diseases. Penumbra's core products include aspiration systems, thrombectomy devices, and embolization products, which are used by healthcare professionals to improve patient outcomes worldwide.

PEN Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Penumbra, Inc. demonstrated strong financial performance with significant growth in the U.S. thrombectomy business and an improvement in gross margins. However, challenges in international markets, particularly in China, and flat gross margin expectations for Q2 present some concerns.Read More>

PEN Stock 12 Month Forecast

Average Price Target

$313.17

▲(33.60%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"170":"$170","341":"$341","212.75":"$212.8","255.5":"$255.5","298.25":"$298.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":340,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$340.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":313.17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$313.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":260,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$260.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[170,212.75,255.5,298.25,341],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,250.68,257.5507692307692,264.4215384615385,271.2923076923077,278.1630769230769,285.0338461538462,291.9046153846154,298.7753846153846,305.6461538461539,312.5169230769231,319.3876923076923,326.2584615384616,333.1292307692308,{"y":340,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,250.68,255.4869230769231,260.2938461538462,265.10076923076923,269.90769230769234,274.7146153846154,279.52153846153846,284.32846153846157,289.1353846153846,293.94230769230774,298.7492307692308,303.55615384615385,308.36307692307696,{"y":313.17,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,250.68,251.3969230769231,252.11384615384617,252.83076923076925,253.5476923076923,254.26461538461538,254.98153846153846,255.69846153846154,256.4153846153846,257.1323076923077,257.84923076923076,258.56615384615384,259.2830769230769,{"y":260,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":177.09,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":171.25,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":202.32,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":191.56,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":233.3,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":244.84,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":237.48,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":266.97,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":285.44,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":271.13,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.82,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":256.16,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":250.68,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >